FDA Compliance for Peptide Therapy and BPC 157 Holt Law Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York